Search results for “Telomere Lengthening” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 42 patents, we discovered top 13 key players by total patent application. Elixirgen Therapeutics, Inc., Elixirgen LLC, Juvensis Therapeutics Co., Ltd. are dominant in this area. They take 59.52% of the total patent filing.
STARTUP
Elixirgen Therapeutics, Inc.
United States
Patent: 17
Elixirgen LLC
United States
Patent: 5
Juvensis Therapeutics Co., Ltd.
China
Patent: 3
Nanjing Yufang Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 2
Guanhao Biotech Co., Ltd.
Guangdong Sheng, China
Patent: 1
GemVax & KAEL Co., Ltd.
South Korea
Patent: 1
Optigenex, Inc.
New Jersey, United States
Patent: 1
Osato International Inc.
Japan
Patent: 1
Beihao Research Institute
Guangdong Sheng, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Elixirgen Therapeutics, Inc.
United States
Patent: 17
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Elixirgen Therapeutics, Inc., Nanjing Yufang Biotechnology Co., Ltd., Juvensis Therapeutics Co., Ltd. take 32.43% of patent filing during this period.
STARTUP
Elixirgen Therapeutics, Inc.
United States
Patent: 6
Nanjing Yufang Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Juvensis Therapeutics Co., Ltd.
China
Patent: 3
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 2
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 2
Osato International Inc.
Japan
Patent: 1
Nanjing Medical University
Shaanxi Sheng, China
Patent: 1
Optigenex, Inc.
New Jersey, United States
Patent: 1
SNC Stemcell Engineering Group Co., Ltd.
China
Patent: 1
Hangzhou Duanli Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 37 patents in last 5 years, we discover 10 new entrants. Nanjing Yufang Biotechnology Co., Ltd., Juvensis Therapeutics Co., Ltd., F. Hoffmann-La Roche Ltd. are the most active new entrants in this area.
Nanjing Yufang Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Juvensis Therapeutics Co., Ltd.
China
Patent: 3
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 2
Osato International Inc.
Japan
Patent: 1
Nanjing Medical University
Shaanxi Sheng, China
Patent: 1
Hangzhou Duanli Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Optigenex, Inc.
New Jersey, United States
Patent: 1
Université Claude Bernard Lyon 1
France
Patent: 1
SNC Stemcell Engineering Group Co., Ltd.
China
Patent: 1
Texas Tech University System
Texas, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 7 universities and scientific research institutions by total patent application. The Johns Hopkins University, University of Rochester, Sun Yat-Sen University are dominant in this area. They take 56.25% of the total patent filing.
The Johns Hopkins University
United States
Patent: 2
University of Rochester
New York, United States
Patent: 2
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 1
Université Claude Bernard Lyon 1
France
Patent: 1
Texas Tech University System
Texas, United States
Patent: 1
Nankai University
Tianjin Shi, China
Patent: 1
Nanjing Medical University
Shaanxi Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: